Clinical Trial

Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment

Study acronym: SCOUT
Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the effectiveness of a PSMA-PET scan in identifying recurrent prostate cancer after focal therapy
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-05-30; most recent amendment 2026-03-20.
Status change: Not Yet Recruiting → Recruiting 2025-08-15
Trial Details
NCT Number NCT07011342
Lead Sponsor Hackensack Meridian Health
Collaborators: Blue Earth Diagnostics
Conditions Prostate Cancer
Enrollment 70 participants
Start Date 2025-10-01
Primary Completion 2028-11 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-23